- NCCN •
- 28 March, 2025 •
- •
Pacritinib in patients with intermediate-1 risk myelofibrosis: outcomes from post-hoc analysis of two Phase 3 studies
Pankit Vachhani, Nikolai Podoltsev, Ashwin Kishtagari, Purvi Suthar, Michael Vredenburg , Karisse Roman-Torres, Aaron Gerds
Available materials